Galectin Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AFFINITY ASSET ADVISORS, LLC | 02/13/2025 | 2.49 M | $3.21 M | 105.71% | 4.00% |
| VANGUARD GROUP INC | 02/11/2025 | 2.14 M | $2.76 M | 0.16% | 3.43% |
| BLACKROCK, INC. | 02/07/2025 | 1.65 M | $2.13 M | 2.79% | 2.65% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 1.34 M | $1.73 M | 360.34% | 2.16% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 1.20 M | $1.55 M | 140.00% | 1.93% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1.18 M | $3.25 M | 0.00% | 1.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 870.59 K | $1.12 M | 0.93% | 1.40% |
| CITADEL ADVISORS LLC | 02/14/2025 | 578.70 K | $746.52 K | 825.92% | 0.93% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 450.20 K | $580.76 K | 2,767.52% | 0.72% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 422.00 K | $544.38 K | 100.00% | 0.68% |
| WEALTHSPIRE ADVISORS, LLC | 02/04/2025 | 398.37 K | $513.90 K | 0.00% | 0.64% |
| GENEOS WEALTH MANAGEMENT INC. | 01/21/2025 | 388.94 K | $501.73 K | 10.20% | 0.62% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 348.20 K | $449.18 K | 138.17% | 0.56% |
| MORGAN STANLEY | 02/14/2025 | 290.08 K | $374.21 K | 17.88% | 0.47% |
| STATE STREET CORP | 02/14/2025 | 287.51 K | $370.89 K | 14.54% | 0.46% |
| NORTHERN TRUST CORP | 02/14/2025 | 244.27 K | $315.11 K | 4.27% | 0.39% |
| ATRIA WEALTH SOLUTIONS, INC. | 01/31/2025 | 207.10 K | $267.16 K | 0.00% | 0.33% |
| 01/29/2025 | 186.01 K | $213.92 K | 100.00% | 0.30% | |
| RETIREMENT GUYS FORMULA LLC | 01/29/2025 | 155.34 K | $200.39 K | 143.42% | 0.25% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 155.00 K | $199.95 K | 0.00% | 0.25% |
| SOLTIS INVESTMENT ADVISORS LLC | 01/29/2025 | 140.75 K | $181.57 K | 0.00% | 0.23% |
| LPL FINANCIAL LLC | 02/11/2025 | 138.93 K | $179.22 K | 69.61% | 0.22% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 134.52 K | $174.00 K | -72.16% | 0.22% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/14/2025 | 118.59 K | $153.00 K | 3.37% | 0.19% |
| CUTTER & CO BROKERAGE, INC. | 02/04/2025 | 115.49 K | $148.98 K | 0.00% | 0.19% |
| LMR PARTNERS LLP | 02/14/2025 | 100.00 K | $129.00 K | 100.00% | 0.16% |
| JANE STREET GROUP, LLC | 02/14/2025 | 89.50 K | $115.46 K | 100.00% | 0.14% |
| CITADEL ADVISORS LLC | 02/14/2025 | 78.40 K | $101.14 K | 51.94% | 0.13% |
| HAP TRADING, LLC | 02/13/2025 | 75.00 K | $281.25 K | 100.00% | 0.12% |
| JANE STREET GROUP, LLC | 02/14/2025 | 70.10 K | $90.43 K | 100.00% | 0.11% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 65.07 K | $83.94 K | 0.00% | 0.10% |
| JPMORGAN CHASE & CO | 02/12/2025 | 59.69 K | $77.00 K | 94.90% | 0.10% |
| 01/31/2025 | 58.41 K | $73.02 K | -26.17% | 0.09% | |
| TRAYNOR CAPITAL MANAGEMENT, INC. | 01/17/2025 | 55.67 K | $71.81 K | 29.85% | 0.09% |
| BARCLAYS PLC | 02/13/2025 | 54.63 K | $71.00 K | 91.11% | 0.09% |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 02/10/2025 | 53.74 K | $69.33 K | 4.39% | 0.09% |
| UBS GROUP AG | 02/14/2025 | 51.78 K | $66.80 K | 261.29% | 0.08% |
| STRATOS WEALTH PARTNERS, LTD. | 01/27/2025 | 51.55 K | $66.50 K | 27.44% | 0.08% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 03/17/2025 | 51.51 K | $66.45 K | 46.76% | 0.08% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 50.83 K | $65.57 K | 18.97% | 0.08% |
| SYNOVUS FINANCIAL CORP | 02/13/2025 | 48.00 K | $61.92 K | 0.00% | 0.08% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 47.52 K | $61.30 K | 43.86% | 0.08% |
| VIVALDI CAPITAL MANAGEMENT LP | 02/14/2025 | 45.63 K | $55.67 K | 89.86% | 0.07% |
| WOLVERINE TRADING, LLC | 02/14/2025 | 45.10 K | $49.61 K | 100.00% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 38.36 K | $49.48 K | 101.44% | 0.06% |
| BLAIR WILLIAM & CO/IL | 02/12/2025 | 37.88 K | $48.87 K | 0.00% | 0.06% |
| SOLUTIONS 4 WEALTH, LTD | 01/28/2025 | 36.00 K | $46.44 K | 0.00% | 0.06% |
| WOLVERINE TRADING, LLC | 02/14/2025 | 35.80 K | $39.38 K | 100.00% | 0.06% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 28.57 K | $36.86 K | 100.00% | 0.05% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 27.62 K | $35.63 K | 0.00% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Galectin Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 98 institutional investors and hedge funds held shares of Galectin Therapeutics Inc.. The most heavily invested institutionals were:
Cutter & CO Brokerage, Inc.: 0
SG Americas Securities, LLC: 0
Larson Financial Group LLC: 0
Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 0
VANGUARD GROUP INC: 2.14 M
ADVISOR GROUP HOLDINGS, INC.: 1.18 M
16.18% of Galectin Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.62 M shares in the last 24 months. This purchase volume represents approximately $14.76 M in transactions.